Johnson & Johnson (JNJ)
145.74
+0.47
(+0.32%)
USD |
NYSE |
Dec 24, 13:00
145.80
+0.06
(+0.04%)
After-Hours: 13:48
Johnson & Johnson Research and Development Expense (Quarterly): 4.952B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Eli Lilly and Co | 2.734B |
Merck & Co Inc | 5.862B |
Pfizer Inc | 2.598B |
AbbVie Inc | 2.13B |
Bristol-Myers Squibb Co | 2.374B |